Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Nebulizers - Medical Devices Pipeline Product Landscape, 2021

Published by GlobalData Product code 995621
Published Content info 50 Pages
Delivery time: 1-2 business days
Price
Back to Top
Nebulizers - Medical Devices Pipeline Product Landscape, 2021
Published: March 10, 2021 Content info: 50 Pages
Description

GlobalData's Medical Devices sector report, "Nebulizers - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Nebulizers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. It turns liquid medicine into mist (aerosol) to treat asthma, COPD, cystic fibrosis, and other respiratory disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Table of Contents
Product Code: GDME1104EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Nebulizers Overview

3 Products under Development

  • 3.1 Nebulizers - Pipeline Products by Stage of Development
  • 3.2 Nebulizers - Pipeline Products by Segment
  • 3.3 Nebulizers - Pipeline Products by Territory
  • 3.4 Nebulizers - Pipeline Products by Regulatory Path
  • 3.5 Nebulizers - Pipeline Products by Estimated Approval Date
  • 3.6 Nebulizers - Ongoing Clinical Trials

4 Nebulizers - Pipeline Products under Development by Companies

  • 4.1 Nebulizers Companies - Pipeline Products by Stage of Development
  • 4.2 Nebulizers - Pipeline Products by Stage of Development

5 Nebulizers Companies and Product Overview

  • 5.1 Ablynx NV Company Overview
  • 5.2 Aeon Research & Technology Company Overview
  • 5.3 AFT Pharmaceuticals Ltd Company Overview
  • 5.4 Aura Medical Company Overview
  • 5.5 Baby's Breath Ltd. Company Overview
  • 5.6 Bridgesource Medical Corp Company Overview
  • 5.7 Creare LLC Company Overview
  • 5.8 DesignWise Medical Inc (Inactive) Company Overview
  • 5.9 HCmed Innovations Co Ltd Company Overview
  • 5.10 Marquette University Company Overview
  • 5.11 Parion Sciences Inc Company Overview
  • 5.12 RMIT University Company Overview
  • 5.13 SolAeroMed Inc Company Overview
  • 5.14 Stirling Pharma Inc Company Overview
  • 5.15 Teleflex Inc Company Overview
  • 5.16 University of California San Diego Company Overview
  • 5.17 University of Texas Medical Branch at Galveston Company Overview
  • 5.18 Verona Pharma Plc Company Overview
  • 5.19 Vincent Medical Holdings Ltd Company Overview
  • 5.20 Wellinks Inc Company Overview

6 Nebulizers- Recent Developments

  • 6.1 Feb 17, 2021: U of M's Technological Leadership Institute names Professor Allison Hubel new director
  • 6.2 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
  • 6.3 Feb 16, 2021: Owens & Minor will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 24, 2021
  • 6.4 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
  • 6.5 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
  • 6.6 Feb 04, 2021: Cardinal Health Earnings Preview
  • 6.7 Jan 12, 2021: Vectura Group: Trading update
  • 6.8 Sep 09, 2020: AstraZeneca Alliance and NEBUCOR nebulizers subscribe for the benefit of asthma patients

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Nebulizers - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Segment
  • Nebulizers - Pipeline Products by Territory
  • Nebulizers - Pipeline Products by Regulatory Path
  • Nebulizers - Pipeline Products by Estimated Approval Date
  • Nebulizers - Ongoing Clinical Trials
  • Nebulizers Companies - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Stage of Development
  • Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
  • Customised Infant Inhalation Device - Product Status
  • Customised Infant Inhalation Device - Product Description
  • Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • LYNX Nebulizer - Product Status
  • LYNX Nebulizer - Product Description
  • AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • NasoSURF - Product Status
  • NasoSURF - Product Description
  • AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
  • NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
  • Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Nebican - Product Status
  • Nebican - Product Description
  • Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • WiseAir - Product Status
  • WiseAir - Product Description
  • Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Breath-Adaptive Nebulizer - Product Status
  • Breath-Adaptive Nebulizer - Product Description
  • Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • DDC-Based Nebulizer - Product Status
  • DDC-Based Nebulizer - Product Description
  • DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Self-Contained Nebulizer System - Product Status
  • Self-Contained Nebulizer System - Product Description
  • HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • AdheResp - Product Status
  • AdheResp - Product Description
  • Marquette University Pipeline Products & Ongoing Clinical Trials Overview
  • Human Powered Nebulizer - Product Status
  • Human Powered Nebulizer - Product Description
  • Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • tPAD Device - Product Status
  • tPAD Device - Product Description
  • RMIT University Pipeline Products & Ongoing Clinical Trials Overview
  • UAS Nebulizer - Product Status
  • UAS Nebulizer - Product Description
  • SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • S1226 Neublizer System - Product Status
  • S1226 Neublizer System - Product Description
  • Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • High Density Aerosol Drug Delivery Device - Product Status
  • High Density Aerosol Drug Delivery Device - Product Description
  • Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • TURBOMIST - Product Status
  • TURBOMIST - Product Description
  • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Nebulizer - Product Status
  • Nebulizer - Product Description
  • University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Pulse Drug Nebulization System - Product Status
  • Pulse Drug Nebulization System - Product Description
  • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • RPL554 Nebulizer - Product Status
  • RPL554 Nebulizer - Product Description
  • Verona Pharma Plc - Ongoing Clinical Trials Overview
  • RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 weeks (with a 48-week Safety Subset) in Subjects with Moderate to Severe COPD
  • RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
  • Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Home Use Ultrasonic Nebulizer - Product Status
  • Home Use Ultrasonic Nebulizer - Product Description
  • Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Bluetooth Enabled Flyp Nebulizer - Product Status
  • Bluetooth Enabled Flyp Nebulizer - Product Description
  • Glossary

List of Figures

List of Figures

  • Nebulizers - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Segment
  • Nebulizers - Pipeline Products by Territory
  • Nebulizers - Pipeline Products by Regulatory Path
  • Nebulizers - Pipeline Products by Estimated Approval Date
  • Nebulizers - Ongoing Clinical Trials
Back to Top